^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    GS-4528

    i
    Other names: GS-4528
    Associations

    News

    Trials
    Company:
    Gilead
    Drug class:
    IL-2 stimulant
    Related drugs:
    Associations

    News

    Trials
    3ms
    Study of GS-4528 in Adults With Solid Tumors (clinicaltrials.gov)
    P1, N=182, Recruiting, Gilead Sciences | N=132 --> 182
    Enrollment change • Combination therapy • Metastases
    |
    Yutuo (zimberelimab) • GS-4528
    over1year
    Study of GS-4528 in Adults With Solid Tumors (clinicaltrials.gov)
    P1, N=132, Recruiting, Gilead Sciences | Not yet recruiting --> Recruiting
    Enrollment open • Combination therapy • Metastases
    |
    Yutuo (zimberelimab) • GS-4528